CD82 protein expression detected by immunohistochemical staining, was reported to be significantly associated with the axillary lymph node status and advanced tumor stage, but no correlation was observed with the hormonal receptor (HR) or Human Epidermal Growth Factor- 2 (HER-2) receptor status [44,45]. Here, CD82 is linked to neoplasm.